What does CUSIP 462260100 represent in this 13F holders report?

CUSIP 462260100 is the security identifier for IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock in Q4 2018?

134 institutional investors reported IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock for Q4 2018. Use the holders table for investor-level position and value details.

IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA)

CUSIP: 462260100

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock
Shares outstanding: 395,322,451
Total 13F shares: 118,553,949
Share change: +27,756,319
Total reported value: $1,048,865,157
Put/Call ratio: 40%
Price per share: $8.85
Number of holders: 134
Value change: +$237,101,241
Number of buys: 92
Number of sells: 49

Quarterly Holders Quick Answers

What is CUSIP 462260100?
CUSIP 462260100 identifies IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 462260100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Avoro Capital Advisors LLC	13F	Company	2.2%	8,662,720	$97,456,000	—	30 Sep 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.8%	7,290,199	$82,014,000	—	30 Sep 2018	13F
BlackRock Finance, Inc.	13F	Company	1.7%	6,653,978	$74,858,000	—	30 Sep 2018	13F
ORBIMED ADVISORS LLC	13F	Company	1.4%	5,548,326	$62,419,000	—	30 Sep 2018	13F
FRANKLIN RESOURCES INC	13F	Company	1.3%	5,184,153	$58,322,000	—	30 Sep 2018	13F
Broadfin Capital, LLC	13F	Company	1.2%	4,894,361	$55,062,000	—	30 Sep 2018	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.2%	4,725,000	$53,156,000	—	30 Sep 2018	13F
VANGUARD GROUP INC	13F	Company	1%	4,048,782	$45,550,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	1%	3,982,562	$44,806,000	—	30 Sep 2018	13F
GREAT POINT PARTNERS LLC	13F	Company	0.88%	3,496,340	$39,334,000	—	30 Sep 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.84%	3,301,161	$37,138,000	—	30 Sep 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.79%	3,122,499	$35,128,000	—	30 Sep 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.61%	2,430,657	$27,345,000	—	30 Sep 2018	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.56%	2,222,701	$25,005,000	—	30 Sep 2018	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.55%	2,188,331	$24,619,000	—	30 Sep 2018	13F
CREDIT SUISSE AG/	13F	Company	0.39%	1,560,825	$17,559,000	—	30 Sep 2018	13F
FMR LLC	13F	Company	0.39%	1,524,100	$17,146,000	—	30 Sep 2018	13F
FIL Ltd	13F	Company	0.34%	1,336,179	$15,032,000	—	30 Sep 2018	13F
Rhenman & Partners Asset Management AB	13F	Company	0.33%	1,290,495	$14,518,000	—	30 Sep 2018	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.28%	1,121,153	$12,613,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.27%	1,067,266	$12,007,000	—	30 Sep 2018	13F
Allianz Asset Management GmbH	13F	Company	0.24%	945,441	$10,637,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	878,484	$9,882,000	—	30 Sep 2018	13F
QVT Financial LP	13F	Company	0.21%	821,361	$8,748,000	—	30 Sep 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.18%	727,043	$8,179,000	—	30 Sep 2018	13F
Prosight Management, LP	13F	Company	0.18%	715,317	$8,047,000	—	30 Sep 2018	13F
Artal Group S.A.	13F	Company	0.18%	700,000	$7,875,000	—	30 Sep 2018	13F
Nantahala Capital Management, LLC	13F	Company	0.15%	601,710	$6,769,000	—	30 Sep 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.12%	462,016	$5,198,000	—	30 Sep 2018	13F
OSTERWEIS CAPITAL MANAGEMENT INC	13F	Company	0.11%	454,295	$5,111,000	—	30 Sep 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.11%	428,232	$4,817,000	—	30 Sep 2018	13F
ARK Investment Management LLC	13F	Company	0.11%	424,820	$4,779,000	—	30 Sep 2018	13F
C WorldWide Group Holding A/S	13F	Company	0.1%	400,603	$4,507,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.1%	391,781	$4,407,000	—	30 Sep 2018	13F
Stanley-Laman Group, Ltd.	13F	Company	0.1%	377,260	$4,244,000	—	30 Sep 2018	13F
Bank of New York Mellon Corp	13F	Company	0.09%	354,834	$3,992,000	—	30 Sep 2018	13F
Opaleye Management Inc.	13F	Company	0.08%	325,000	$3,656,000	—	30 Sep 2018	13F
NEXTHERA CAPITAL LP	13F	Company	0.08%	296,500	$3,336,000	—	30 Sep 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.07%	296,278	$3,333,000	—	30 Sep 2018	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.07%	280,000	$3,150,000	—	30 Sep 2018	13F
Squarepoint Ops LLC	13F	Company	0.06%	253,000	$2,846,000	—	30 Sep 2018	13F
Endurant Capital Management LP	13F	Company	0.06%	242,169	$2,724,000	—	30 Sep 2018	13F
Tekla Capital Management LLC	13F	Company	0.05%	216,908	$2,440,000	—	30 Sep 2018	13F
Marshall Wace North America L.P.	13F	Company	0.05%	213,182	$2,398,000	—	30 Sep 2018	13F
Cheyne Capital Management (UK) LLP	13F	Company	0.05%	200,000	$2,250,000	—	30 Sep 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.05%	192,536	$2,166,000	—	30 Sep 2018	13F
EMORY UNIVERSITY	13F	Company	0.05%	185,915	$2,092,000	—	30 Sep 2018	13F
Vident Investment Advisory, LLC	13F	Company	0.05%	179,479	$2,019,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	158,458	$1,783,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	0.04%	150,092	$1,688,000	—	30 Sep 2018	13F

Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2018

As of 31 Dec 2018, IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 118,553,949 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, venBio Select Advisor LLC, BlackRock Inc., FRANKLIN RESOURCES INC, Broadfin Capital, LLC, Vanguard Group Inc, FARALLON CAPITAL MANAGEMENT LLC, GREAT POINT PARTNERS LLC, ORBIMED ADVISORS LLC, and STATE STREET CORP. This page lists 134 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

129

Q4 2018 holders

134

Holder diff

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.